Ipidacrine

File:Ipidacrine.svg
Systematic (IUPAC) name
2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinolin-9-amine
Clinical data
Trade names	Neiromidin
Legal status	US: Not FDA approved; unscheduled
Identifiers
ATC code	N06DA05 (WHO)
PubChem	CID: 604519
ChemSpider	525510
ChEMBL	CHEMBL130880
Synonyms	Amiridine; NIK-247
Chemical data
Formula	C12H16N2
Molecular mass	188.27 g/mol
SMILES C1CCc2c(c(c3c(n2)CCC3)N)C1
InChI InChI=1S/C12H16N2/c13-12-8-4-1-2-6-10(8)14-11-7-3-5-9(11)12/h1-7H2,(H2,13,14) Key:YLUSMKAJIQOXPV-UHFFFAOYSA-N

Ipidacrine (Neiromidin) is a drug first synthesized by the National Research Center for Biologically Active Compounds in the Russian Federation. This compound is a derivative of 4-aminopyridine and is structurally similar to tacrine.

Ipidacrine is a reversible acetylcholinesterase inhibitor used in memory disorders of different origins.

Ipidacrine directly stimulates impulse transmission in the central nervous system and neuromuscular synapses by blocking membrane potassium channels. Ipidacrine enhances not only choline, but also adrenaline, serotonin, histamine, and oxytocin effects on smooth muscle.